OHSU innovators
Tell us about a new idea or technology and learn how OHSU could help protect the intellectual property.
Startup support
Interested in forming a new company around your idea? Learn about how OHSU can help with startup company formation.
Collaborations
Learn more about existing OHSU partnerships and opportunities to work with OHSU community members.
Licensing opportunities
Visit the OHSU Technology Portal to search for existing licensing opportunities and review technology summaries.
Agreements
Learn more about commercialization and intellectual property agreements.
Entrepreneurial education
Learn more about OHSU curriculum and programs offered to provide entrepreneurial training to OHSU members.
The 2024 OHSU Innovation Awards
Congratulations to the 2024 OHSU Innovation Awardees Alex Bartlett, Ph.D., Robert Eil, M.D., Michael Riscoe, Ph.D., Joaquin Cigarroa, M.D., Matthias Merkel, M.D., Ph.D., and Joe Ness, M.H.A., RPh. These awards recognize innovative scientists in the OHSU community striving to turn scientific ideas into healthcare solutions to improve patient lives.
Read more about the awardees and their innovative science in the 2024 OHSU Innovation Awards announcement.
Learn more about OHSU Innovates
OHSU Innovates is proud to support researchers and clinicians at OHSU who are striving to turn scientific ideas into real world solutions.
Hear from a few of these OHSU members and learn what motivates them and how OHSU fosters innovation, collaboration and entrepreneurship.
Subscribe to the OHSU Innovates newsletter for the latest news, programs and events.
OHSU Innovators in the News
Autobahn advances therapeutics for psychiatric disorders
OHSU startup company Autobahn Therapeutics announced completion of their series C raise, an oversubscribed $100 million to advance their lead drug target ABX-002. The therapeutic will now head to Phase II clinical trials for major depressive disorder and bipolar disorder. The company spun out of research from the laboratory of Tom Scanlan, Ph.D. Read more in the OHSU News story.
Featured Event
Angel Oregon Life & Bioscience: Investment Announcement Mixer
Join the Oregon Entrepreneurs Network for the Angel Oregon Life & Bioscience (AOBIO) Investment Announcement Mixer. This special evening will celebrate innovations in the life and bioscience industry. Regional startup founders will be in the running to earn an equity investment from the Angel Oregon Life & Bioscience (AOBIO) investor group and will pitch their companies on the main stage. At the end of the day will be the BIG CHECK MOMENT where AOBIO Investors will announce which of the finalists will receive the investment, which is more than $100,000!
When: Nov. 21, 4 – 7 pm
Where: Mission Theater, 1624 NW Glisan Portland, OR
Cost: $15-25
Featured funding opportunity
SBIR/STTR Support
The Phase 0/00 program provides up to $5,000, to be used for SBIR/STTR application support services, including written critiques of Phase I, Phase II (Phase 00) or Fast-track proposals, grant writing assistance, and additional services that help increase the competitiveness of the application. Phase 0/00 application are due a minimum of 4 weeks prior to SBIR/STTR due date.
See the Request for Applications for more details.
OHSU Innovates collaborative network
Innovate Collaborate Oregon
OHSU Innovates is a proud partner of Innovate Collaborate Oregon (ICOregon), a collaborative network of Oregon institutions, which aims to further support and encourage the growth of innovation and entrepreneurship across the state. By bringing together resources across multiple institutions ICOregon aims to promote innovative discoveries, establish successful collaborations, form new companies, and increase economic development in Oregon.
Support OHSU Innovates
Become a sponsor
Learn more about how your organization can support innovation and entrepreneurship at OHSU and across the region.
Support innovation at OHSU
Help OHSU drive regional economic impact through entrepreneurship.
Learn more about the IDEA fund.